Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Wealth management tools for families can simplify financial oversight and planning. Learn about the best tools to help manage your family's wealth efficiently.
21,408 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A potential federal shift on cannabis could redefine the playing field for Canopy Growth, Tilray, and Green Thumb. Th...
In 2026, two retail powerhouses—Chewy and Walmart—face very different growth paths. This guide dissects their models,...
Small-cap growth has propelled some funds to the top this year. Discover the overlooked Vanguard outpacing this rally...
Volatility creates noise, but it can also reveal the best buying opportunity months for patient investors. Learn wher...
Bloom Energy has surged in 2026 on AI infrastructure bets, but a July pullback raises questions about the stock's nex...
A major Vanguard growth ETF is underperforming the S&P 500 this year. Here's how concentration in mega-cap tech shape...
Public Masterpiece launches PMT Chain, a dedicated Layer 1 for authenticating real-world assets. The move redefines t...
Apple shares regained ground as AI plans take center stage ahead of a major March event. This guide breaks down what’...
A single Vanguard mega-cap ETF has a heavy tilt toward four tech giants. This deep dive explains what that concentrat...
Rumors around chip supply and product timelines can move markets quickly. This guide shows how AMD typically responds...
A new, sizable stake in Cal-Maine Foods hints at investor conviction despite a halved income last quarter. This piece...